Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
APC |
adenomatous polyposis coli, transcript variant 3 |
FXC01190
|
FHC01190
|
FNC01190N
|
FNC01190C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
BCL2 |
B-cell CLL/lymphoma 2, transcript variant alpha |
FXC01250
|
FHC01250
|
FNC01250N
|
FNC01250C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
FXC01934
|
FHC01934
|
FNC01934N
|
FNC01934C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
MLH1 |
mutL homolog 1, transcript variant 1 |
FXC03755
|
FHC03755
|
FNC03755N
|
FNC03755C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
APPL1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
FXC04145
|
FHC04145
|
FNC04145N
|
FNC04145C
|
BIRC5 |
baculoviral IAP repeat containing 5, transcript variant 1 |
FXC04272
|
FHC04272
|
FNC04272N
|
FNC04272C
|
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa, transcript variant 1 |
FXC07714
|
FHC07714
|
FNC07714N
|
FNC07714C
|
MSH2 |
mutS homolog 2, transcript variant 1 |
FXC07773
|
FHC07773
|
FNC07773N
|
FNC07773C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
MSH6 |
mutS homolog 6, transcript variant 1 |
FXC08173
|
FHC08173
|
FNC08173N
|
FNC08173C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
ANAPC2 |
anaphase promoting complex subunit 2 |
FXC10289
|
FHC10289
|
FNC10289N
|
FNC10289C
|
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
FXC10312
|
FHC10312
|
FNC10312N
|
FNC10312C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
BAX |
BCL2-associated X protein, transcript variant beta |
FXC10662
|
FHC10662
|
FNC10662N
|
FNC10662C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
DCC |
DCC netrin 1 receptor |
FXC10740
|
FHC10740
|
FNC10740N
|
FNC10740C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
AXIN1 |
axin 1, transcript variant 2 |
FXC11116
|
FHC11116
|
FNC11116N
|
FNC11116C
|
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box), transcript variant 4 |
FXC11660
|
FHC11660
|
FNC11660N
|
FNC11660C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
AXIN2 |
axin 2 |
FXC11955
|
FHC11955
|
FNC11955N
|
FNC11955C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MSH3 |
mutS homolog 3 |
FXC12698
|
FHC12698
|
FNC12698N
|
FNC12698C
|
LEF1 |
lymphoid enhancer-binding factor 1, transcript variant 2 |
FXC16601
|
FHC16601
|
FNC16601N
|
FNC16601C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
FXC21071
|
FHC21071
|
FNC21071N
|
FNC21071C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
TCF7 |
transcription factor 7 (T-cell specific, HMG-box), transcript variant 1 |
FXC22279
|
FHC22279
|
FNC22279N
|
FNC22279C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
JAK1 |
Janus kinase 1 |
FXC01306
|
FHC01306
|
FNC01306N
|
FNC01306C
|
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
FXC01313
|
FHC01313
|
FNC01313N
|
FNC01313C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor), transcript variant 2 |
FXC01466
|
FHC01466
|
FNC01466N
|
FNC01466C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific, transcript variant 2 |
FXC01544
|
FHC01544
|
FNC01544N
|
FNC01544C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
FXC02618
|
FHC02618
|
FNC02618N
|
FNC02618C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
BCL2L1 |
BCL2-like 1, transcript variant 1 |
FXC03091
|
FHC03091
|
FNC03091N
|
FNC03091C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant 1 |
FXC04167
|
FHC04167
|
FNC04167N
|
FNC04167C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
CASP9 |
caspase 9, transcript variant alpha |
FXC08062
|
FHC08062
|
FNC08062N
|
FNC08062C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
RALBP1 |
ralA binding protein 1 |
FXC08672
|
FHC08672
|
FNC08672N
|
FNC08672C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
RAD51 |
RAD51 recombinase, transcript variant 1 |
FXC10574
|
FHC10574
|
FNC10574N
|
FNC10574C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
TGFA |
transforming growth factor, alpha |
FXC10823
|
FHC10823
|
FNC10823N
|
FNC10823C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
FXC11836
|
FHC11836
|
FNC11836N
|
FNC11836C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
FXC21157
|
FHC21157
|
FNC21157N
|
FNC21157C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
BRCA2 |
BRCA2, DNA repair associated |
FXC24976
|
FHC24976
|
FNC24976N
|
FNC24976C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha, transcript variant 2 |
FXC00158
|
FHC00158
|
FNC00158N
|
FNC00158C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
FXC01207
|
FHC01207
|
FNC01207N
|
FNC01207C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
FXC01262
|
FHC01262
|
FNC01262N
|
FNC01262C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
CALM3 |
calmodulin 3 (phosphorylase kinase, delta) |
FXC01403
|
FHC01403
|
FNC01403N
|
FNC01403C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1), transcript variant 1 |
FXC01536
|
FHC01536
|
FNC01536N
|
FNC01536C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
PLCG1 |
phospholipase C, gamma 1, transcript variant 1 |
FXC01646
|
FHC01646
|
FNC01646N
|
FNC01646C
|
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta, transcript variant 6 |
FXC01765
|
FHC01765
|
FNC01765N
|
FNC01765C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1, transcript variant 3 |
FXC03742
|
FHC03742
|
FNC03742N
|
FNC03742C
|
CAMK2B |
calcium/calmodulin-dependent protein kinase II beta, transcript variant 5 |
FXC04424
|
FHC04424
|
FNC04424N
|
FNC04424C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
CALML3 |
calmodulin-like 3 |
FXC09388
|
FHC09388
|
FNC09388N
|
FNC09388C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PTEN |
phosphatase and tensin homolog, transcript variant 1 |
FXC09870
|
FHC09870
|
FNC09870N
|
FNC09870C
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
FXC10206
|
FHC10206
|
FNC10206N
|
FNC10206C
|
CAMK2G |
calcium/calmodulin-dependent protein kinase II gamma, transcript variant 2 |
FXC10307
|
FHC10307
|
FNC10307N
|
FNC10307C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
TGFA |
transforming growth factor, alpha |
FXC10823
|
FHC10823
|
FNC10823N
|
FNC10823C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CALM2 |
calmodulin 2 (phosphorylase kinase, delta), transcript variant 2 |
FXC11793
|
FHC11793
|
FNC11793N
|
FNC11793C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
CALML5 |
calmodulin-like 5 |
FXC23748
|
FHC23748
|
FNC23748N
|
FNC23748C
|
SHC4 |
SHC (Src homology 2 domain containing) family, member 4 |
FXC25382
|
FHC25382
|
FNC25382N
|
FNC25382C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1), transcript variant 1 |
FXC01536
|
FHC01536
|
FNC01536N
|
FNC01536C
|
CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
MITF |
microphthalmia-associated transcription factor, transcript variant 1 |
FXC03436
|
FHC03436
|
FNC03436N
|
FNC03436C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
PTEN |
phosphatase and tensin homolog, transcript variant 1 |
FXC09870
|
FHC09870
|
FNC09870N
|
FNC09870C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|